Evolution Biotechnologies US is a development-stage biotechnology company focused on companion animal diseases as a novel, low-cost approach to bring phage therapy to market. Based in Georgetown, Texas, the company is building on its unique experience and skill set in developing bacteriophage-based therapeutics. The company is interested in talking with potential collaborators in the field of companion animal medicine.
Bacteriophage product pipeline:
- Product under development – target: Pseudomonas aeruginosa and Staphylococcus aureus